Skip to main content

Day: June 1, 2022

SCOR successfully sponsors a new catastrophe bond, Atlas Capital Reinsurance 2022 DAC

Press ReleaseJune 1, 2022 – N° 12 SCOR successfully sponsors a new catastrophe bond, Atlas Capital Reinsurance 2022 DAC SCOR has successfully sponsored a new catastrophe bond (“cat bond”), Atlas Capital Reinsurance 2022 DAC, which will provide the Group with a multi-year risk transfer capacity of USD 240 million to protect itself against named storms in the U.S. and earthquakes in the U.S. and Canada, as well as European windstorms. The risk period for Atlas Capital Reinsurance 2022 will run from June 1st, 2022, to May 31, 2025. The transaction has received the approval of the Irish regulatory authorities. The cat bond offering integrates ESG related considerations to support investors’ due diligence. The cat bond was priced on May 23rd, 2022 and closed on May 27th, 2022. GC Securities1 acted as sole structuring agent and joint-bookrunner...

Continue reading

Notice of Annual General Meeting in ZetaDisplay AB (publ)

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail.NOTICE OF ANNUAL GENERAL MEETING IN ZETADISPLAY AB (PUBL)The shareholders of ZetaDisplay AB (publ) reg. no. 556603-4434 (the “Company”) are hereby given notice of the Annual General Meeting (the “AGM”) to be held on 30 June 2022. The Company’s annual general meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. There will be no meeting with the possibility to attend in person or to be represented by a proxy. ZetaDisplay welcomes all shareholders to exercise their voting rights at the AGM through advance voting as described below. Information on the resolutions passed at the AGM will be published on 30 June 2022 as soon as the result of the advance voting...

Continue reading

Zhong Yang Financial Group Limited Announces Pricing of $25,000,000 Initial Public Offering

Hong Kong China, June 01, 2022 (GLOBE NEWSWIRE) — Zhong Yang Financial Group Limited (the “Company”) (NASDAQ: TOP), a fast-growing online brokerage firm located in Hong Kong specializing in the trading of local and foreign equities, futures, options products and other financial services, today announced the pricing of its initial public offering (the “Offering”) of 5,000,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $5.00 per share for total gross proceeds of $25,000,000 before deducting underwriting discounts and offering expenses. The Offering is being conducted on a firm commitment basis. The Ordinary Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading today, June 1, 2022, under the ticker symbol “TOP”. The...

Continue reading

SRAX to Host Full Year Earnings Conference Call on Monday, June 6th, 2022

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will announce Q4 and Full Year earnings for 2021 this Monday, June 6th, 2022. Conference Call: SRAX’s Founder and CEO Christopher Miglino, and CFO Michael Malone will provide an operational and financial summary for Full Year 2021 on a video call, with a live question and answer session, on Monday, June 6th, at 10:30 am ET / 7:30 am PT. To register for the live webcast and view the presentation, please sign up here: https://audience.mysequire.com/webinar-view?webinar_id=b431d84a-22ca-475f-bd11-be0df096edb0 To access the conference by phone: Dial in: +1 346-248-7799 Meeting ID: 92139622922 Passcode: 432792 SRAX was previously...

Continue reading

8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period

Singapore, May 31, 2022 (GLOBE NEWSWIRE) — 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the SPA (the “SPA Amendment”) to extend the time for LAX to complete its financial, operational and legal due diligence review of EUDA Health from May 31, 2022 to June 15, 2022. As previously announced, LAX entered into a Share Purchase Agreement (the “SPA”) dated April 11, 2022, with Euda Health Limited (“EUDA Health”), Watermark Developments Limited, a British Virgin Islands business company (the “Seller”), and Kwong...

Continue reading

ClimateRock Announces the Separate Trading of its Class A Ordinary Shares, Rights, and Warrants Commencing June 2, 2022

United Kingdom, May 31, 2022 (GLOBE NEWSWIRE) —  ClimateRock (NASDAQ: CLRCU) (the “Company”), a newly organized blank check company incorporated as a Cayman Islands exempted company and led by Chairman, Charles Ratelband V and CEO, Per Regnarsson, announced today that commencing on June 2, 2022, holders of the units sold in the Company’s initial public offering of 7,875,000 units completed on May 2, 2022 may elect to separately trade the Company’s Class A ordinary shares (“Class A Ordinary Shares”), rights, and warrants included in the units. Once the securities comprising the units begin separate trading, the Class A Ordinary Shares, rights, and warrants will be traded on the Nasdaq Global Market under the symbols “CLRC,” “CLRCR” and “CLRCW,” respectively. Those units not separated will continue to trade on the NASDAQ Global...

Continue reading

Prospera Provides Second Status Update

CALGARY, Alberta, May 31, 2022 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“Prospera” or the “Corporation“) (PEI:TSX-V; OTC:GXRFF; FRA:OF6B) provides its second bi-weekly Status Report under National Policy 12-203 Management Cease Trade Orders (“NP 12-203“), pursuant to which Prospera issued its original default announcement indicating that the filing of its annual audited financial statements, annual management’s discussion and analysis, and related CEO and CFO certifications for the year ended December 31, 2021 (the “Required Disclosure“), would be delayed beyond the filing deadline of April 30, 2022. Prospera reports that since issuing the original default announcement on May 3, 2022, there has been no material changes to the information contained therein that has not been disclosed,...

Continue reading

Operational Highlights and Financial Results for the Period Ended March 31, 2022

Substantial Reduction in Operational Spend while Maintaining Focus on BLA Resubmission NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended March 31, 2022. Financial HighlightsNet cash usage reported for operating activities in the quarter was reduced by 40%, or US$10.3 million, to US$15.5 million compared with US$25.8 million in the comparative quarter last year1 For the quarter, net cash usage reported for operating activities, excluding inventory for the planned remestemcel-L product launch, was reduced by 50% to US$11.2 million from US$22.2 million in the comparative quarter For the nine-month period ended March 31, 2022, net cash usage reported...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.